Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Abstract Background In juvenile idiopathic arthritis (JIA) clinical remission is unattainable in some patients despite modern biologic disease-modifying antirheumatic drugs (bDMARD) therapy and switching bDMARD is required. The best choice of second-line bDMARD remains unclear. This retrospective ob...
Saved in:
Main Authors: | Mia Lindegaard Pedersen (Author), Amalie Neve-Græsbøll (Author), Troels Herlin (Author), Mia Glerup (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Switching to an alternative biological agent in juvenile idiopathic arthritis (I)
by: Gonzalez MI, et al.
Published: (2011) -
Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience
by: Katriina Mikola, et al.
Published: (2022) -
Smallest detectable differences in clinical variables related to temporomandibular joint arthritis in juvenile idiopathic arthritis
by: Herlin Troels, et al.
Published: (2011) -
Restricted upper airway dimensions in patients with dentofacial deformity from juvenile idiopathic arthritis
by: Xiaowen Niu, et al.
Published: (2022) -
Impact of physiotherapy on orofacial manifestations of juvenile idiopathic arthritis
by: Stratos Vassis, et al.
Published: (2023)